Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK.

J Natl Cancer Inst. 2006 Apr 5;98(7):441-50.

PMID:
16595780
2.

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.

Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, Vincent MD, Lembersky BC, Thompson S, Maniero A, Benner SE.

J Clin Oncol. 2002 Sep 1;20(17):3605-16.

PMID:
12202661
3.

Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.

Shin DM, Glisson BS, Khuri FR, Clifford JL, Clayman G, Benner SE, Forastiere AA, Ginsberg L, Liu D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK, Lippman SM.

J Clin Oncol. 2002 Jan 15;20(2):364-70.

PMID:
11786562
4.

The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.

Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, Fu KK, Cooper JS, Vokes EE, Chamberlain RM, Williams B, Pajak TF, Goepfert H, Hong WK.

Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):823-9.

5.

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.

Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, Okawara G, Woodhouse CL, Williams B, Perez C, Kim HW, Lotan R, Roth JA, Hong WK.

J Natl Cancer Inst. 2001 Apr 18;93(8):605-18.

PMID:
11309437
6.

Predicting cancer development in oral leukoplakia: ten years of translational research.

Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu XC, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK, Lippman SM.

Clin Cancer Res. 2000 May;6(5):1702-10.

7.

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma.

Mani S, Schiano T, Garcia JC, Ansari RH, Samuels B, Sciortino DF, Tembe S, Shulman KL, Baker A, Benner SE, Vokes EE.

Invest New Drugs. 1998-1999;16(3):279-83.

PMID:
10360610
8.

UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.

Hoff PM, Pazdur R, Benner SE, Canetta R.

Anticancer Drugs. 1998 Jul;9(6):479-90. Review.

PMID:
9877235
9.

Uracil-ftorafur: an oral fluoropyrimidine active in colorectal cancer.

Sulkes A, Benner SE, Canetta RM.

J Clin Oncol. 1998 Oct;16(10):3461-75. Review.

PMID:
9779725
10.

The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levels.

Lippman SM, Benner SE, Fritsche HA Jr, Lee JS, Hong WK.

Cancer Detect Prev. 1998;22(1):51-6.

PMID:
9466049
11.

A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.

Huber MH, Lippman SM, Benner SE, Shirinian M, Dimery IW, Dunnington JS, Hong WK.

Am J Clin Oncol. 1996 Aug;19(4):379-82.

PMID:
8677909
12.

Clinical studies in head and neck cancer chemoprevention.

Gonzalez PM, Benner SE.

Cancer Metastasis Rev. 1996 Mar;15(1):113-8. Review.

PMID:
8842482
13.
14.

Chemoprevention of lung cancer.

Benner SE, Lippman SM, Hong WK.

Chest. 1995 Jun;107(6 Suppl):316S-321S. Review.

PMID:
7781413
15.

Current status of retinoid chemoprevention of lung cancer.

Benner SE, Lippman SM, Hong WK.

Oncology (Williston Park). 1995 Mar;9(3):205-10; discussion 210, 213-4, 216. Review.

16.

Retinoids and chemoprevention: clinical and basic studies.

Lippman SM, Heyman RA, Kurie JM, Benner SE, Hong WK.

J Cell Biochem Suppl. 1995;22:1-10. Review.

PMID:
8538183
17.

Biology and reversal of aerodigestive tract carcinogenesis.

Lippman SM, Clayman GL, Huber MH, Benner SE, Hong WK.

Cancer Treat Res. 1995;74:89-115. Review. No abstract available.

PMID:
7779624
18.

Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.

Huber MH, Lippman SM, Benner SE, Shirinian M, Dimery IW, Earley CL, Winn RJ, Brooks J, Baez L, Hong WK.

Ann Oncol. 1995 Jan;6(1):83-5.

19.

Toxicity of isotretinoin in a chemoprevention trial to prevent second primary tumors following head and neck cancer.

Benner SE, Pajak TF, Stetz J, Lippman SM, Hong WK, Schantz SP, Gallagher MJ, Shenouda G.

J Natl Cancer Inst. 1994 Dec 7;86(23):1799-801. No abstract available.

PMID:
7966422
20.

Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy.

Benner SE, Lippman SM, Wargovich MJ, Lee JJ, Velasco M, Martin JW, Toth BB, Hong WK.

Int J Cancer. 1994 Nov 15;59(4):457-9.

PMID:
7960211
21.

Epidemiology, biology, and chemoprevention of aerodigestive cancer.

Lippman SM, Spitz M, Trizna Z, Benner SE, Hong WK.

Cancer. 1994 Nov 1;74(9 Suppl):2719-25. Review.

PMID:
7954292
22.

Retinoid lung cancer prevention.

Benner SE, Lippman SM, Hong WK.

Lung Cancer. 1994 Nov;11 Suppl 3:S71-8. Review. No abstract available.

PMID:
7704516
23.

Retinoid chemoprevention of second primary tumors.

Benner SE, Lippman SM, Hong WK.

Semin Hematol. 1994 Oct;31(4 Suppl 5):26-30. Review.

PMID:
7831582
24.

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

Lee JS, Lippman SM, Benner SE, Lee JJ, Ro JY, Lukeman JM, Morice RC, Peters EJ, Pang AC, Fritsche HA Jr, et al.

J Clin Oncol. 1994 May;12(5):937-45.

PMID:
8164045
25.

Cancer chemoprevention.

Lippman SM, Benner SE, Hong WK.

J Clin Oncol. 1994 Apr;12(4):851-73. Review.

PMID:
8151328
26.

Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.

Lippman SM, Benner SE, Hong WK.

Cancer Res. 1994 Apr 1;54(7 Suppl):2025s-2028s. Review.

27.

Second international cancer chemoprevention conference.

Benner SE, Pastorino U, Lippman SM, Hong WK.

Cancer Res. 1994 Feb 1;54(3):854-6. No abstract available.

28.

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up.

Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK.

J Natl Cancer Inst. 1994 Jan 19;86(2):140-1. No abstract available.

PMID:
8271298
29.

Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.

Benner SE, Wargovich MJ, Lippman SM, Fisher R, Velasco M, Winn RJ, Hong WK.

Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):73-6.

30.
31.

Chemoprevention of second primary tumours: a model for intervention trials.

Benner SE, Lippman SM, Hong WK.

Eur J Cancer. 1994;30A(6):727-9. Review. No abstract available.

PMID:
7917527
32.

Evolution of aerodigestive tract 13-cis-retinoid acid chemoprevention: the M.D. Anderson experience.

Hong WK, Benner SE, Lippman SM.

Leukemia. 1994;8 Suppl 3:S33-7. Review.

PMID:
7808022
33.

Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck.

Huber MH, Dimery IW, Benner SE, Lippman SM, Shirinian M, Esparaz B, Frenning D, Guillory-Perez C, Hong WK.

Invest New Drugs. 1994;12(4):327-31.

PMID:
7775135
34.

Clinical chemoprevention: developing a cancer prevention strategy.

Benner SE, Hong WK.

J Natl Cancer Inst. 1993 Sep 15;85(18):1446-7. No abstract available.

PMID:
8360923
35.

Retinoids in chemoprevention of head and neck carcinogenesis.

Lippman SM, Benner SE, Hong WK.

Prev Med. 1993 Sep;22(5):693-700. Review.

PMID:
8234209
36.

Chemoprevention. Strategies for the control of cancer.

Lippman SM, Benner SE, Hong WK.

Cancer. 1993 Aug 1;72(3 Suppl):984-90. Review.

PMID:
8334674
37.

Squamous metaplasia of the bronchial mucosa and its relationship to smoking.

Peters EJ, Morice R, Benner SE, Lippman S, Lukeman J, Lee JS, Ro JY, Hong WK.

Chest. 1993 May;103(5):1429-32.

PMID:
8486022
38.

N-(4-hydroxyphenyl) retinamide is anticlastogenic in human lymphoblastoid cell lines.

Trizna Z, Benner SE, Shirley L, Furlong C, Hong WK.

Anticancer Res. 1993 Mar-Apr;13(2):355-6.

PMID:
7685988
39.

Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study.

Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, Hong WK.

J Natl Cancer Inst. 1993 Jan 6;85(1):44-7.

PMID:
8416256
40.

Chemoprevention strategies in lung carcinogenesis.

Lippman SM, Benner SE, Hong WK.

Chest. 1993 Jan;103(1 Suppl):15S-19S. Review.

PMID:
8416769
41.

Micronuclei: a potential intermediate marker for chemoprevention of aerodigestive tract cancer.

Benner SE, Wargovich MJ, Lippman SM, Hong WK.

J Cell Biochem Suppl. 1993;17F:250-4. Review.

PMID:
8412201
42.

Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis.

Benner SE, Lippman SM, Wargovich MJ, Velasco M, Peters EJ, Morice RC, Hong WK.

Int J Cancer. 1992 Aug 19;52(1):44-7.

PMID:
1500226
43.

Current status of chemoprevention of head and neck cancer.

Benner SE, Lippman SM, Hong WK.

Oncology (Williston Park). 1992 Aug;6(8):61-6; discussion 66-8, 71 passim.

PMID:
1386997
44.

Prevention of Second Head and Neck Cancers.

Benner SE, Lippman SM, Hong WK.

Semin Radiat Oncol. 1992 Jul;2(3):206-212. No abstract available.

PMID:
10717036
45.

Chemoprevention strategies for lung and upper aerodigestive tract cancer.

Benner SE, Lippman SM, Hong WK.

Cancer Res. 1992 May 1;52(9 Suppl):2758s-2763s. Review.

46.

Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials.

Benner SE, Hong WK, Lippman SM, Lee JS, Hittelman WM.

J Cell Biochem Suppl. 1992;16G:33-8. Review.

PMID:
1469903
47.
48.

Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer.

Benner SE, Clark GM, McGuire WL.

Am J Med Sci. 1988 Jul;296(1):59-66. Review.

PMID:
3044107

Supplemental Content

Loading ...
Support Center